34 studies found for:    " September 17, 2008":" October 17, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" September 17, 2008":" October 17, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (34 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Enrolling by invitation Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
Conditions: Influenza;   Acquired Immune Deficiency Syndrome;   HIV Infections
Intervention: Biological: Mesotherapy
2 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
3 Terminated Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
Condition: HIV Infections
Intervention: Drug: Angiotensin 1-7
4 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
5 Completed Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Behavioral Drug and HIV Risk Reduction Counseling (BDRC);   Behavioral: Drug counseling
6 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
7 Recruiting Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
8 Completed
Has Results
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
9 Completed Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
Conditions: Latent Tuberculosis;   HIV Infections
Intervention: Other: T-Spot.TB test
10 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
11 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
12 Completed Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
13 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
14 Completed Efficacy of Influenza Vaccine in HIV Infected Adults
Conditions: HIV;   Influenza;   Vaccination;   HIV Infections
Intervention: Biological: MUTAGRIP
15 Completed
Has Results
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
Condition: Human Immunodeficiency Virus
Intervention: Drug: Comparator: raltegravir
16 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
17 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
18 Completed Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
19 Active, not recruiting Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Condition: HIV Infections
Interventions: Drug: Tenofovir + emtricitabine + efavirenz;   Drug: Tenofovir + emtricitabine + lopinavir/ritonavir
20 Completed
Has Results
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Condition: HIV
Interventions: Drug: ritonavir;   Drug: darunavir;   Drug: emtricitabine [FTC]/tenofovir [TDF];   Drug: atazanavir

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years